切换至 "中华医学电子期刊资源库"
高级检索
中华医学超声杂志（电子版）

中华医学超声杂志（电子版） ›› 2020, Vol. 17 ›› Issue (04) : 315 -319. doi: 10.3877/cma.j.issn.1672-6448.2020.04.005

所属专题： 文献；

腹部超声影像学

三维可视化术前规划系统辅助超声引导微波消融联合肝动脉化疗栓塞治疗大肝癌效果的初步研究
袁迎春1, 袁晓春2, 王琦3, 高元瑾4, 刘方义4, 于晓玲4,†()   
  1. 1. 750004　宁夏医科大学总医院超声科
    2. 750004　宁夏医科大学总医院急诊科
    3. 750004　宁夏医科大学总医院肝胆外科
    4. 100853　北京，解放军总医院第一医学中心介入超声科
  • 收稿日期:2019-11-13 出版日期:2020-04-01
  • 通信作者: 于晓玲

Ultrasound-guided percutaneous microwave ablation assisted by three-dimensional planning system combined with transhepatic arterial chemoembolization for treating single large hepatocellular carcinoma: a primary study of survival

Yingchun Yuan1, Xiaochun Yuan2, Qi Wang3, Yuanjin Gao4, Fangyi Liu4, Xiaoling Yu4,†()   

  1. 1. Department of Ultrasound, General Hospital of Ningxia Medical University, Yinchuang 750004, China
    2. Department of Emergency Medicine, General Hospital of Ningxia Medical University, Yinchuang 750004, China
    3. Department of Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuang 750004, China
    4. Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing 100853, China
  • Received:2019-11-13 Published:2020-04-01
  • Corresponding author: Xiaoling Yu
  • About author:
    Corresponding author: Yu Xiaoling, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

袁迎春, 袁晓春, 王琦, 高元瑾, 刘方义, 于晓玲. 三维可视化术前规划系统辅助超声引导微波消融联合肝动脉化疗栓塞治疗大肝癌效果的初步研究[J/OL]. 中华医学超声杂志（电子版）, 2020, 17(04): 315-319.

Yingchun Yuan, Xiaochun Yuan, Qi Wang, Yuanjin Gao, Fangyi Liu, Xiaoling Yu. Ultrasound-guided percutaneous microwave ablation assisted by three-dimensional planning system combined with transhepatic arterial chemoembolization for treating single large hepatocellular carcinoma: a primary study of survival[J/OL]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2020, 17(04): 315-319.

目的

评估三维可视化术前规划系统辅助超声引导下，经皮穿刺肝内病灶微波消融治疗直径大于5 cm的单病灶原发性肝细胞肝癌的安全性及临床应用价值。

方法

选取2015年5月至2017年8月在解放军总医院介入超声科接受微波消融治疗的40例患者，这些患者病灶均为单发大于5 cm原发性肝细胞肝癌，其中21例接受无三维术前规划的常规超声引导下经皮穿刺肝内病灶微波消融治疗，19例接受三维可视化术前规划辅助超声引导下肝内病灶微波消融治疗，采用Kaplan-Meier及Log-rank检验比较2组间有无复发生存及总生存的差异。

结果

三维术前规划组和无三维术前规划组1、3年总生存率分别为94.7%、38.5%，100.0%、34.4%，差异无统计学意义（P=0.745）；1、3年无进展生存率分别为100.0%、64.6%，89.5%、18.8%，差异有统计学意义（χ2=1.210，P=0.014）。两组患者均未出现消融相关严重并发症及死亡。

结论

三维可视化术前规划辅助超声引导下肝内病灶微波消融治疗大于5 cm原发性肝癌可提高消融治疗的无肿瘤进展生存率，并表现出较好的安全性，将为消融治疗提供新的辅助手段，为进一步智能消融治疗打下基础。

关键词: 成像，三维, 超声检查，介入性, 消融技术, 肝肿瘤
Objective

To evaluate the safety and clinical efficacy of three-dimensional (3D) visualization preoperative planning system assisted ultrasound-guided percutaneous microwave ablation for treating single large hepatocellular carcinoma (HCC).

Methods

Forty patients with a single large HCC (diameter ≥ 5 cm) from May 2015 to August 2017 were included, of whom 21 received ultrasound-guided percutaneous microwave ablation without 3D visualization assistance and 19 patients were treated under the assistance of 3D visualization. Survival and recurrence were recorded and compared between the two groups.

Results

The 1-year and 3-year overall survival rates of the 3D visualization group and no 3D visualization group were 94.7% and 38.5%, and 100% and 34.4%, respectively, which showed no statistical difference (P=0.745). The 1-year and 3-year recurrence free survival rates of the two groups were 100% and 64.6%, and 89.5% and 18.8%, respectively, which showed statistical differences (P=0.014). No severe complication or death occurred in either group.

Conclusion

3D visualization assisted ultrasound guided microwave ablation for primary liver cancer larger than 5 cm can improve the recurrence free survival rate and demonstrate good safety, thus providing a new auxiliary method for ablation and laying a foundation for intelligent ablation.

Key words: Imaging, three-dimensional, Ultrasonography, interventional, Ablation techniques, Liver neoplasms
图1 患者中年男性，体检发现右肝占位，超声造影检查图像。图a上：动脉期；下：延迟期，提示肝S7段占位，大小约54 mm×52 mm，结合病史诊断为原发性肝细胞肝癌。术前行三维术前规划，术后再次利用三维规划评估手术效果；图b上：术前磁共振及三维重建图像；下：术后磁共振及三维重建图像
表1 HCC患者三维规划组与无三维规划组一般资料比较
组别 例数 性别 年龄（岁，±s） 肿瘤最大径（cm，±s） Child-Pugh分级 消融前TACE治疗
男性 女性 A级 B级
三维规划组 19 94.7% 5.3% 59.4±9.86 6.1±1.13 73.7% 26.7% 73.7%
无三维规划组 20 95.0% 5.0% 61.4±8.15 6.0±0.78 87.5% 14.3% 81.0%
统计值   χ2=0.902 t=-0.706 t=0.249 χ2=0.902 χ2=0.302
P值   0.342 0.484 0.804 0.342 0.583
1
Zuo TT, Zheng RS, Zhang SW, et al. Incidence and mortality of liver cancer in China in 2011 [J]. Chin J Cancer, 2015, 34(11): 508-513.
2
Liapi E, Geschwind JF. Intra-arterial therapies for hepatocellular carcinoma: where do we stand? [J]. Ann Surg Oncol, 2010, 17(5): 1234-1246.
3
Poulou LS, Botsa E, Thanou I, et al. Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma [J]. World J Hepatol, 2015, 7(8): 1054-1063.
4
Sacco R, Tapete G, Simonetti N, et al. Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review [J]. J Hepatocell Carcinoma, 2017, 4: 105-110.
5
de Lope CR, Tremosini S, Forner A, et al. Management of HCC [J]. J Hepatol, 2012, 56 Suppl 1: S75-S87.
6
Facciorusso A, Serviddio G, Muscatiello N. Local ablative treatments for hepatocellular carcinoma: an updated review [J]. World J Gastrointest Pharmacol Ther, 2016, 7(4): 477-489.
7
Lucchina N, Tsetis D, Ierardi A M, et al. Current role of microwave ablation in the treatment of small hepatocellular carcinomas [J]. Ann Gastroenterol, 2016, 29(4): 460-465.
8
Groeschl RT, Pilgrim CH, Hanna EM, et al. Microwave ablation for hepatic malignancies: a multiinstitutional analysis [J]. Ann Surg, 2014, 259(6): 1195-1200.
9
Medhat E, Abdel Aziz A, Nabeel M, et al. Value of microwave ablation in treatment of large lesions of hepatocellular carcinoma [J]. J Dig Dis, 2015, 16(8): 456-463.
10
Tamai T, Oshige A, Tabu K, et al. Utility of percutaneous radiofrequency ablation alone or combined with transarterial chemoembolization for early hepatocellular carcinoma [J]. Oncol Lett, 2017, 14(3): 3199-3206.
11
Zuo TY, Liu FY, Wang MQ, et al. Transcatheter Arterial Chemoembolization Combined with Simultaneous Computed Tomography-guided Radiofrequency Ablation for Latge Hepatocellulat Carcinomas [J]. Chin Med J (Engl), 2017, 130(22): 2666-2673.
12
Yan JY, Zhang JL, Wang MQ, et al. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm [J]. Asia Pac J Clin Oncol, 2018, 14(4): 300-309.
13
Xu G, Chen C, Zheng W, et al. IQQA-3D imaging interpretation and analysis system-guided single-port video-assisted thoracic surgery for anatomical sub-segmentectomy (LS1+ 2a+ b) [J]. J Thorac Dis, 2018, 10(9): 5515-5521.
14
Wang F, Zhang C, Guo F, et al. Navigation of Intelligent/Interactive Qualitative and Quantitative Analysis Three-Dimensional Reconstruction Technique in Laparoscopic or Robotic Assisted Partial Nephrectomy for Renal Hilar Tumors [J]. J Endourol, 2019, 33(8): 641-646.
15
Wang XD, Wang HG, Shi J, et al. Traditional surgical planning of liver surgery is modified by 3D interactive quantitative surgical planning approach: a single-center experience with 305 patients [J]. Hepatobiliary Pancreat Dis Int, 2017, 16(3): 271-278.
16
Ferrero A, Viganò L, Polastri R, et al. Postoperative liver dysfunction and future remnant liver: where is the limit? [J]. World J Surg, 2007, 31(8): 1643-1651.
17
Guglielmi A, Ruzzenente A, Conci S, et al. How much remnant is enough in liver resection? [J]. Dig Surg, 2012, 29(1): 6-17.
18
姜春林, 汤地, 王晔, 等. 三维手术模拟系统在巨大肝癌精准肝切除中的应用 [J]. 中华消化外科杂志, 2012, 11(2): 111-115.
[1] 章建全, 程杰, 陈红琼, 闫磊. 采用ACR-TIRADS评估甲状腺消融区的调查研究[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(10): 966-971.
[2] 罗辉, 方晔. 品管圈在提高甲状腺结节细针穿刺检出率中的应用[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(10): 972-977.
[3] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[4] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[5] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[6] 李云龙, 夏旭良, 江志强, 刘伟, 刘凯, 唐立, 刘昊中, 张思远. 三种方法治疗分化型甲状腺癌的临床疗效[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 487-489.
[7] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[8] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[9] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[10] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
[11] 林小勇, 张兰霞, 曾庆劲, 贺需旗, 谭雷, 郭光辉, 龙颖琳, 李凯, 吴宇轩. 负压抽吸活检针在肝困难病灶活检中的初步应用研究[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 694-698.
[12] 雷永琪, 刘新阳, 杨黎渝, 铁学宏, 俞星新, 耿志达, 刘雨, 陈政良, 惠鹏, 梁英健. 肝脏血管周上皮样细胞肿瘤合并贫血一例并文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 710-718.
[13] 欧阳佳裕, 李刚, 贺露瑶, 罗娜. 双层探测器光谱CT在早期原发性肝癌中的诊断价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 557-561.
[14] 陈志坚, 俞建达, 池小斌, 吕立志, 陈永标. 三维可视化技术在腹腔镜肝巨大肿瘤切除中的应用价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 302-307.
[15] 黄俊豪, 陈宗杰, 胡添松. 血小板相关参数对肝内胆管细胞癌根治性切除患者预后预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 308-312.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号

AI
小
编
AI小编
你好！我是《中华医学电子期刊资源库》AI小编，有什么可以帮您的吗？